Navigation Links
Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Date:10/1/2010

PHILADELPHIA, Oct. 1 /PRNewswire/ -- Kibow has recently completed a pilot-scale study wherein Kibow(R) Biotics were administered orally to a limited number of patients in USA, Canada, Argentina and Nigeria. The positive outcome from this study has just been published in the September issue of the peer-reviewed "Advances in Therapy" journal. This report, titled "Pilot Study of Probiotic Dietary Supplementation for Promoting Health Kidney Function in Patients with Chronic Kidney Disease," can be accessed freely at the company's website (http://www.kibow.com) or the journal's website (http://www.advancesintherapy.com).

The company's flagship product, Kibow(R) Biotics, utilizes a patented and proprietary bowel-based enteric technology concept for use in clinical applications towards maintaining a healthy kidney function. Dr. Natarajan Ranganathan, Interim CEO and VP Research and Development, stated, "By developing an affordable, readily available and easy-to-administer dietary supplement, Kibow offers hope to all those who suffer from kidney problems in the USA and other countries worldwide in accordance with their respective governmental regulatory/registration authorities."

Kibow Biotech is also pleased to announce its successful completion of its 13th year of business today. To celebrate this milestone, Kibow is participating for the second year in the 9th annual National Kidney Foundation Kidney Walk, which will be taking place October 3rd, 2010 at the Philadelphia Zoo. In addition, Kibow would also like to take this time to announce its venture into social networking, with its first official Facebook page, "Probiotics for Kidney Health." Visitors are invited to leave comments, share their experiences, or view news links, photos, and videos. This will help interested people keep up with the latest research stories, see what's happening at Kibow Biotech, and more imp
'/>"/>

SOURCE Kibow Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kibow Biotech Strongly Supports World Kidney Day for Maintenance of Healthy Kidney Function
2. Kibow Biotech, Inc. Launches Breakthrough Probiotic Dietary Supplement for Kidney Health in USA and Canada
3. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Yongye Biotechnology International Retains CCG Investor Relations
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
8. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
9. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
10. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
11. China Kangtai Cactus Biotech Announces Record Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... Nuvilex, Inc. (OTCQB: NVLX) – According to ... are living with diabetes, with  that number expected to ... market for diabetes treatments is approximately $500 billion.  ... from pancreatic cancer.  Pancreatic cancer is the fourth most ... the United States , and according to ...
(Date:10/20/2014)... 20, 2014 Mapp Biopharmaceutical,s valiant effort ... therapeutic to fight the Ebola outbreak will make ... the production of pharmaceuticals can be, according to ... that while some may be taken aback by ... with industry knowledge are well aware of the ...
(Date:10/20/2014)... , A major pan-European survey ... delivery of care has revealed changing trends in many ... the provision of healthcare services across the continent. The ... European Gastroenterology (UEG), have been announced today and led ... the burden of GI disorders across Europe ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5
... and to Complete Current Phase 3 Trial of Naturlose(R) ... June 23 Spherix Incorporated (Nasdaq: SPEX ... a provider of technical and regulatory consulting services to ... it has received its first full-scale production batch of ...
... Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced ... once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day ... an inhaled lethal dose of anthrax. All of the ... (the human equivalent dose of 300 mg) of Restanza ...
... VIENNA, Austria, June 23 MIG ... Venture Capital & Private Equity Award,competition, hosted by the industry ... between the,German venture fund and the Austrian biotechnology company as ... Biologicals. , Last Tuesday MIG Fonds ...
Cached Biology Technology:Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 2Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 3Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 4Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 2Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 3AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 2AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 3
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
(Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
(Date:10/15/2014)... pneumonia in female mice to an enzyme activated by ... more resistant to respiratory infections than males. Now, an ... to bacterial pneumonia in female mice is linked to ... show that this enzyme is ultimately activated by the ... team, lead by Professor Lester Kobzik at the Harvard ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... ecological sustainability of biofuels and the impact of their ... will take place on Friday, Dec. 5, in Panama ... Forests: Trends, Implications and Emerging Alternatives, is sponsored by ... Program in Native Species Reforestation, both joint programs of ...
... "Waterproof" versions of popular varieties of rice, which can ... farmers, fields with flying colors. Several of these varieties are ... certification agencies in Bangladesh and India, where farmers suffer major ... tons of rice per year. This is enough rice to ...
... Department of Plant Biology and Biotechnology at the ... been granted the Danisco Award 2008. She received ... secondary metabolites, which are biologically active substances in, ... has focused on biosynthetic pathways, regulation and transport ...
Cached Biology News:Conference to explore sustainability of biofuels 2From genes to farmers' fields 2From genes to farmers' fields 3The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2
... Trap is specifically designed for efficient ... as DMSO and DMF in the ... refrigeration system set at -5 o ... DMSO, while completely eliminating the risk ...
Thermo Forma provides an array of accessory Racks for the Cryo/CryoPlus 16" Diameter storage system. To maximise inventory capacity a Jumbo Arrowhead configuration is recommended. You may choose betw...
... combine high durability and capacity with unequalled ... mechanism prevents vibration, allowing the unit to ... other part, from the large rubber block ... aluminum platform is designed to last through ...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: